MSK PRO
ActiveSummary
MSK PRO is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €23,645 and a net result of €20,645. Its solvency ranks better than 66% of 16666 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record50
Credit verdict
Credit up to €2,000 at 30 days acceptable
Liquidity ample (current ratio 4.5; short-term debt: 22.2% and cash: 9.9% of total assets), and 22.2% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-09-2026, 56 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filingDeviation from the deadline
2025
56 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€23,645
Total assets
€30,408
Net result
€20,645
Working capital
€23,645
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Equity and liabilities €30,408
Equity
€23,645
Debt
€6,763
Debt finances 22.2% of the balance-sheet total.
Key figures and ratios
Current ratio
4.50
Debt to equity
0.29
ROE
87.3%
ROA
67.9%
Debt ≤ 1 year
€6,763
Income taxes
€5,311
Annual accounts
| Line | 2025 |
|---|---|
| Gross operating margin9900 | €25,956 |
| Operating profit (loss)9901 | €25,956 |
| Profit (loss) for the period before taxes9903 | €25,956 |
| Income taxes67/77 | €5,311 |
| Profit (loss) for the period9904 | €20,645 |
| Profit (loss) for the period to be appropriated9905 | €20,645 |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €30,408 | |
| Current assets29/58 | €30,408 | |
| Amounts receivable within one year40/41 | €27,408 | |
| Other amounts receivable41 | €27,408 | |
| Cash at bank and in hand54/58 | €3,000 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €30,408 | |
| Equity10/15 | €23,645 | |
| Contributions10/11 | €3,000 | |
| Reserves13 | €20,645 | |
| Distributable reserves133 | €20,645 | |
| Amounts payable17/49 | €6,763 | |
| Amounts payable within one year42/48 | €6,763 | |
| Trade debts44 | €1,452 | |
| Suppliers440/4 | €1,452 | |
| Taxes, remuneration and social security45 | €5,311 | |
| Taxes450/3 | €5,311 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €20,645 |
| Operating cash flow (approximation) | €20,645 |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2026
25-09
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 56 days late
NBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Profondeville · 1 establishment unit since 2025
Ground area
1,213 m²
Building footprint
190 m²
Volume, LiDAR
1,443 m³
2 parcels, Wallonia · tallest building 16.0 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
MSK PRO
since 20252.382.703.347
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92101A0050/00F012 | Wallonia | 823 m² | 1 · 87 m² | 8.3 m · 2 fl. |
| 92067B0583/00A000 | Wallonia | 390 m² | 1 · 103 m² | 15.9 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PAREL-LIER
BE 0659.804.193
Lier · Eq €23,651
KineKompas
BE 1017.160.806
Lommel · Eq €23,719
VANDERSARREN VIRGINIE
BE 0600.997.251
Harelbeke · Eq €23,520
REFUEL Antwerp
BE 0794.651.219
Antwerpen · Eq €23,777
WAVI CONSULTING
BE 0638.787.164
Rixensart · Eq €23,484
Of 12,699 companies in sector 86951 we hold annual accounts for 2,146. 1,888 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded22-12-2025
Fiscal year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
E-invoicing
Reachable via Peppol
Peppol ID
0208:1032010912
Registered
05-01-2026
Register as of 26 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.